Metabolic consequences of erastin-induced ferroptosis in human ovarian cancer cells: an untargeted metabolomics study
IntroductionOvarian cancer has been difficult to cure due to acquired or intrinsic resistance and therefore, newer or more effective drugs/approaches are needed for a successful treatment in the clinic. Erastin (ER), a ferroptosis inducer, kills tumor cells by generating and accumulating reactive ox...
Saved in:
Main Authors: | Kaylie I. Kirkwood-Donelson, Alan K. Jarmusch, Carl D. Bortner, Bruce Alex Merrick, Birandra K. Sinha |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Molecular Biosciences |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmolb.2024.1520876/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Non-invasive electron paramagnetic resonance imaging detects tumor redox imbalance induced by ferroptosis
by: Kazuhiro Kato, et al.
Published: (2025-12-01) -
Dicoumarol sensitizes hepatocellular carcinoma cells to ferroptosis induced by imidazole ketone erastin
by: Ziwei Yang, et al.
Published: (2025-02-01) -
Niraparib restricts intraperitoneal metastases of ovarian cancer by eliciting CD36-dependent ferroptosis
by: Ning Jin, et al.
Published: (2025-03-01) -
Synergistic effects of PS-NPs and Cd on ovarian toxicity in adolescent rats: Ferroptosis by induction of mitochondrial redox imbalance via the SIRT3-SOD2/Gpx4 pathway
by: Hua Wu, et al.
Published: (2025-01-01) -
LPCAT3 regulates the proliferation and metastasis of serous ovarian cancer by modulating arachidonic acid
by: Fang Wen, et al.
Published: (2025-02-01)